Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127183621 | 12718362 | 1 | I | 20160704 | 20160824 | 20160906 | 20160906 | EXP | FR-TEVA-688480ROM | TEVA | 68.00 | YR | M | Y | 0.00000 | 20160906 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127183621 | 12718362 | 1 | PS | TEVAGRASTIM | FILGRASTIM | 1 | Intravenous (not otherwise specified) | 48 MU DAILY; | Y | NAV | 125294 | 48 | MIU | QD | |||||
| 127183621 | 12718362 | 2 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | Y | 0 | ||||||||||
| 127183621 | 12718362 | 3 | SS | BENDAMUSTINE HYDROCHLORIDE. | BENDAMUSTINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 137 | MG | /cycle | ||||||||
| 127183621 | 12718362 | 4 | SS | rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | Y | 0 | 367 | MG | /cycle | |||||||
| 127183621 | 12718362 | 5 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1 DOSAGE FORM = 800 MG SULFAMETHOXAZOLE + 160 MG TRIMETHOPRIM. TOOK THREE DAYS PER WEEK | Y | 0 | TABLET | ||||||||
| 127183621 | 12718362 | 6 | SS | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1000 MILLIGRAM DAILY; | Y | 0 | 500 | MG | FILM-COATED TABLET | BID | |||||
| 127183621 | 12718362 | 7 | C | COTAREG | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | 0 | FILM-COATED TABLET | |||||||||||
| 127183621 | 12718362 | 8 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127183621 | 12718362 | 1 | Neutropenia |
| 127183621 | 12718362 | 2 | Prophylaxis |
| 127183621 | 12718362 | 3 | Chronic lymphocytic leukaemia |
| 127183621 | 12718362 | 4 | Chronic lymphocytic leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127183621 | 12718362 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127183621 | 12718362 | Dermatitis exfoliative | |
| 127183621 | 12718362 | Pruritus | |
| 127183621 | 12718362 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127183621 | 12718362 | 1 | 20160704 | 20160704 | 0 | |
| 127183621 | 12718362 | 3 | 20160613 | 20160727 | 0 | |
| 127183621 | 12718362 | 4 | 20160613 | 20160727 | 0 | |
| 127183621 | 12718362 | 5 | 20160613 | 20160711 | 0 | |
| 127183621 | 12718362 | 6 | 20160613 | 20160711 | 0 |